Company / Current Liabilities per Share
FATE THERAPEUTICS INC Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.32
FY2025
5-year range
$0.32 / $1.19
FY2021-FY2025
Trend
-18.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has declined for 3 consecutive years, from $1.19 in FY2022 to $0.32 in FY2025.
Based on SEC 10-K filings.
0.32 in FY2025 with a 5-year CAGR of -22.5%.
Improved from $0.40 to $0.32 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -35.7%
- 5-Year CAGR
- -22.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- FATE THERAPEUTICS INC's current liabilities per share has declined for 3 consecutive years.
- In FY2025, current liabilities per share decreased 18.9% year-over-year.
- Peak current liabilities per share was recorded in FY2022.
- Lowest current liabilities per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 632.81 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.32 | -18.9% |
| FY2024 | $0.39 | -2.8% |
| FY2023 | $0.40 | -66.3% |
| FY2022 | $1.19 | +28.6% |
| FY2021 | $0.93 | -18.0% |
| FY2020 | $1.13 | +162.9% |
| FY2019 | $0.43 | -17.0% |
| FY2018 | $0.52 | +94.0% |
| FY2017 | $0.27 | -49.5% |
| FY2016 | $0.53 | -19.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026